Medicines, Technologies, and Pharmaceutical Services (MTaPS) program.   2

The purpose of this notice is to comply with the synopses and pre-solicitation notice requirements of FAR 5.2 - Synopsis of Proposed Contract Actions. Any solicitation resulting from this notice will be handled in accordance with FAR 5.102(d); therefore, availability of any resulting solicitation package may be limited to this electronic medium.

This is NOT a Request for Proposal (RFP) and in no way obligates the US Government to issue an RFP and/or award a contract. The information herein below is released for wide dissemination to all parties and is indicative only. The information is subject to modification and is in no way binding to government and the estimate is based on the best information available at this time.
The purpose of the Medicines, Technologies, and Pharmaceutical Services (MTaPS) is to strengthen low-and middle-income country health systems to ensure sustainable access to and appropriate use of safe, effective, quality-assured, affordable essential medicines and medicines-related services. In furtherance of this purpose, specific objectives that MTaPS will work to accomplish include:

Objective 1: Pharmaceutical sector governance strengthened

Strengthening pharmaceutical sector governance includes improving transparency and accountability of country pharmaceutical systems; improving and enforcing evidence-based medicines policies, laws, regulations, guidelines, norms, and standards; and increasing stakeholder engagement and empowerment, including civil society and consumers.

Objective 2: Institutional and human resource capacity for pharmaceutical management and services increased, including regulation of medical products

This includes institutionalizing innovative and proven approaches for human resource capacity building; strengthening capacity of government to manage pharmaceutical systems; improving capacity of private sector organizations to support pharmaceutical operations; and strengthening medicines regulatory capacity including through regional regulatory harmonization.

Objective 3: Availability and use of pharmaceutical information for decision-making increased and the global learning agenda advanced

This includes effectively implementing pharmaceutical management information systems that are interoperable and link patients and products; ensuring the availability and use of information on pharmaceutical systems; advancing the pharmaceutical systems strengthening research and global learning agenda.

Objective 4: Pharmaceutical sector financing, including resource allocation and use, optimized

This includes reducing financial barriers to access to medicines; developing and implementing evidence-based medicines strategies and pharmacy benefits programs; increasing efficiency of pharmaceutical resource allocation and use; and increasing mobilization of additional and sustainable resources.

Objective 5: Pharmaceutical services, including product availability and patient-centered care, to achieve desired health outcomes improved

This includes improving availability of essential medicines and other health technologies; improving patient-centered pharmaceutical care; ensuring patient safety and therapeutic effectiveness; and supporting antimicrobial resistance containment.

Subject to the availability of funds, the United States Agency for International Development, (USAID), intends to issue a Request for Proposals (RFP) for a single 5-year contract with a total estimated cost of approximately $150-$170 million, to implement the MTaPS Activity.
The solicitation is anticipated to be released on or about August 23, 2017, and will be made available electronically upon its release to www.fbo.gov. USAID will conduct this procurement through full and open competition, under which any type of organization (large or small commercial [for profit] firms, educational institutions, non-profit organizations) are eligible to compete. USAID encourages the participation to the maximum extent possible of small business concerns, small disadvantaged business concerns and women-owned small business concerns in this activity, or as a subcontractor in accordance with Part 19 of FAR. The NAICS code will be 541990 and the authorized geographic code for this procurement is 935.